Who is sponsoring NCT06264089?

NCT06264089 is sponsored by Yuzuncu Yil University.

What drugs are being tested in NCT06264089?

Interventions in NCT06264089: Preservation Rhinoplasty Nasal Valve Angle and Area.

What condition does NCT06264089 study?

NCT06264089 studies Nasal Obstruction, Bilateral.

Is NCT06264089 still recruiting?

NCT06264089 is currently completed. Last updated 16 February 2024.

Last reviewed 2024-02-16 · How we verify

NCT06264089

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Preservation Rhinoplasty Nasal Valve Angle and Area

Completed NA Last updated 16 February 2024

What this trial tests

NA trial testing Preservation Rhinoplasty Nasal Valve Angle and Area in Nasal Obstruction, Bilateral in 100 participants. Completed in 30 August 2023.

Timeline

6 August 2020

Primary endpoint
30 August 2023

30 August 2023

Quick facts

Lead sponsor	Yuzuncu Yil University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	6 August 2020
Primary completion	30 August 2023
Estimated completion	30 August 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Preservation Rhinoplasty Nasal Valve Angle and Area

Conditions studied

Nasal Obstruction, Bilateral — all drugs for Nasal Obstruction, Bilateral →

Sponsor

Yuzuncu Yil University

Who can join

Adults 18 to 65, any sex, with Nasal Obstruction, Bilateral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study planned to compare the internal nasal valve angle measurements of patients who underwent preservation rhinoplasty before and after surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Yuzuncu Yil University trials

Trials by the same sponsor.

NCT07525297 — Mulligan's Mobilization in Rotator Cuff Pathology · NA · not yet recruiting
NCT07523399 — Joint Health, Balance and Quality of Life in Adults With Hemophilia A · recruiting
NCT07416877 — The Effects of Dual-Task Exercises on Parameters After Total Knee Arthroplasty · NA · not yet recruiting
NCT07243925 — Effect of Family Involvement Intervention on Anxiety, Independence, and Psychological Resilience in CABG Surgery Patient · NA · active not recruiting
NCT07339410 — Physiotherapy to Improve Balance and Walking Capacity in Hemophilia · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06264089 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yuzuncu Yil University
Last refreshed: 16 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06264089.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing